Navigating Transfusion Requirements in PNH Treatment

Heart rate variability (HRV) biofeedback may be a potential intervention for patients with coronary artery disease.

The founder and President of Phesi addresses the need for streamlining clinical trial data as GLP-1 RA therapies are being used to treat multiple diseases.

Venetoclax plus bortezomib and dexamethasone improved PFS in relapsed/refractory multiple myeloma, especially in patients with BCL2high disease.

This Managed Care Cast episode explores how high costs and inconsistent insurance coverage for incretin mimetics impact obesity management and patient care.

COVID-19–related work absences remain elevated post pandemic, especially in high-exposure jobs, highlighting lasting labor market impacts.

A session held during the CHEST 2025 Annual Meeting focused on the North American guidelines for treating bronchiectasis.